• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

How Much Should Your Medical Procedure Cost?

June 13, 2018 By Dr. Jeremy Feldman

medical costs

One of the great mysteries of medicine is how much tests, procedures and doctor’s visits cost. Unlike everything else, there is no price list or actual cost for these things.  Each insurance company and plan has a different negotiated price.  And the price varies depending on if the service is “in-network” or “out-of-network”.  Ironically, patients who are paying with good … [Read more...]

Inhaled Nitric Oxide For Pulmonary Arterial Hypertension

May 30, 2018 By Dr. Jeremy Feldman

blood cells pulmonary arteries

What is Nitric Oxide? Nitric oxide is a small molecule that is made by the cells lining the pulmonary arteries (vascular endothelium).  It acts on the same blood vessels to promote blood vessel relaxation (vasodilation). Since the early 1980’s we have known that patients with Pulmonary Arterial Hypertension have reduced levels of nitric oxide.  When nitric oxide is not present … [Read more...]

Sleep Apnea and Pulmonary Arterial Hypertension

May 17, 2018 By Dr. Jeremy Feldman

sleep apnea man

  Obstructive sleep apnea (OSA) is a very common problem.  Patients with this disorder experience repeated episodes of obstructing their airway when they sleep that culminates in transiently waking up from sleep.  In simple terms this means that they repeatedly choke themselves and wake up for a very short period of time.  Patients don't remember waking-up, as the … [Read more...]

Acceleron Launches a Phase 2 Study of Sotatercept for PAH

May 4, 2018 By Dr. Jeremy Feldman

acceleron Sotatercept drug for PAH

All of our existing therapies for Pulmonary Arterial Hypertension act by vasodilation or relaxing blood vessels.  The current medications fall into one of three basic classes: 1.    PDE5 inhibitor a. Sildenafil (Revatio/Viagra) b. Tadalafil (Adcirca/Cialiis) c. Riociguat (Adempas—not truly a PDE5inhibitor but similar action) 2.    ERA a. Ambrisentan (Letairis) b. … [Read more...]

Liquidia: Exciting New Clinical Trial in Pulmonary Arterial Hypertension

April 19, 2018 By Dr. Jeremy Feldman

PAH research

Clinical trials are essential to improving the care of PAH patients. These clinical trials allow us to determine if new medicines are safe and effective. Clinical trials also allow us to make improvements to existing treatments. For example, we are eagerly awaiting the approval of the implanted pump for intravenous Remodulin. Another example of a company that is trying to … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Oxygen as a treatment for PAH

Do I Need Oxygen?

By Dr. Jeremy Feldman

One of the most common concerns that patients with lung disease express is whether or not they need to use

PAH research

Exciting New Clinical Trials in PAH

By Dr. Jeremy Feldman

The wheels of progress continue to move forward in PAH research.  Two companies in particular are preparing to

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives